Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Stroke is the third leading cause of death in the United States and the leading cause of
serious long-term disability. Approximately 50% of the 750,000 people affected by stroke each
year have residual physical impairment. Treatment options for recovery are limited at this
time. Sildenafil (Viagra) has demonstrated the capability of significantly improving recovery
in several animal experiments of stroke. This study is aiming to establish the safety of
treatment with sildenafil in people with stroke with the ultimate aim of testing its
usefulness to improve recovery.